The use of TruCare III insulin pump in patients with type 1 diabetes mellitus
https://doi.org/10.14341/probl13516
Abstract
The development of devices for continuous subcutaneous insulin infusion (CSII or insulin pumps) dramatically improved medical care for patients with diabetes mellitus. Insulin pump production widens annually resulting in number of new models entering the market, that differs in price but are similar in technical features. The entering of such new models to the Russian market can cause practical issues both in patient and in health care provider, so their estimation is of great importance. Insulin pump TruCare III (Apex Medical Co., Ltd, China) was registered in Russian Federation in September 15, 2023. The clinical experience of the TruCare III use in patients with type 1 diabetes mellitus is presented with the focus on glycemic parameters and custom features.
About the Authors
I. A. Barsukov
Moscow Regional Research and Clinical Institute
Russian Federation
Competing Interests:
Russian Federation
Ilya A. Barsukov - MD, PhD.
61/2–9 Shchepkina street, 129110, Moscow
Competing Interests:
none
A. A. Demina
Moscow Regional Research and Clinical Institute
Russian Federation
Competing Interests:
Russian Federation
Anna A. Demina – MD.
Moscow
Competing Interests:
none
References
1. Dedov I, et al. Standards of Specialized Diabetes Care / Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 11th Edition. Diabetes mellitus. 2023;26(2S):1-157. (In Russ.) doi: https://doi.org/10.14341/DM13042
2. Pala L, Dicembrini I, Mannucci E. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials. Acta Diabetol. 2019;56(9):973-980. doi: https://doi.org/10.1007/s00592-019-01326-5
3. American Diabetes Association. Diabetes technology: standards of medical care in diabetes-2019. Diabetes Care. 2019; 42(suppl 1):S71–S80. doi: https://doi.org/10.2337/dc19-S007
4. Gandhi K, Ebekozien O, Noor N, et al. Insulin Pump Utilization in 2017-2021 for More Than 22,000 Children and Adults With Type 1 Diabetes: A Multicenter Observational Study. Clin Diabetes. 2024;42(1):56-64. doi: https://doi.org/10.2337/cd23-0055
5. Huo L, Deng W, Lan L, et al. Real-World Application of Insulin Pump Therapy Among Patients With Type 1 Diabetes in China: A Cross-Sectional Study. Front Endocrinol (Lausanne). 2022;13:891718. doi: https://doi.org/10.3389/fendo.2022.891718
6. Babiker A, Alammari N, Aljuraisi A, et al. The Effectiveness of Insulin Pump Therapy Versus Multiple Daily Injections in Children With Type 1 Diabetes Mellitus in a Specialized Center in Riyadh. Clin Med Insights Endocrinol Diabetes. 2022;15:11795514221128495. doi: https://doi.org/10.1177/11795514221128495
7. Calderon Martinez E, Castillo JL, Zachariah Saji S, et al. Insulin Pump Therapy vs Multiple Daily Insulin Injections for Glycemic Control in Children With Type 1 Diabetes: A Systematic Review and Meta-Analysis. Cureus. 2024;16(1):e52054. doi: https://doi.org/10.7759/cureus.52054
8. REPOSE Study Group. Relative effectiveness of insulin pump treatment over multiple daily injections and structured education during flexible intensive insulin treatment for type 1 diabetes: cluster randomised trial (REPOSE). BMJ. 2017;356:j1285. doi: https://doi.org/10.1136/bmj.j1285
9. Ferreira M, Neves JS, Neves C, et al. Physical exercise and glycemic management in patients with type 1 diabetes on insulin pump therapy-a cross-sectional study. Acta Diabetol. 2023;60(7):881-889. doi: https://doi.org/10.1007/s00592-023-02070-7
10. Sora ND, Shashpal F, Bond EA, et al. Insulin Pumps: Review of Technological Advancement in Diabetes Management. Am J Med Sci. 2019;358(5):326-331. doi: https://doi.org/10.1016/j.amjms.2019.08.008
Supplementary files
|
|
1. Figure 1. Dynamics of the outpatient glycemic profile in patient A at baseline (A) and after 2 weeks of using the TruCare III insulin pump (B). | |
| Subject | ||
| Type | Research Instrument | |
View
(250KB)
|
Indexing metadata ▾ | |
|
|
2. Figure 2. Dynamics of the outpatient glycemic profile in patient B at baseline (A) and after 2 weeks of using the TruCare III insulin pump (B) | |
| Subject | ||
| Type | Research Instrument | |
View
(250KB)
|
Indexing metadata ▾ | |
Review
For citations:
Barsukov I.A., Demina A.A. The use of TruCare III insulin pump in patients with type 1 diabetes mellitus. Problems of Endocrinology. 2024;70(5):70-75. (In Russ.) https://doi.org/10.14341/probl13516
Views:
2336
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
